Science
Mechanism of Action
Operating at a molecular level, this copolymer integrates into formulations to physically bind disparate ingredients together, thereby contributing to product cohesion and stability. As a film former, it creates a subtle, non-occlusive layer upon application, which helps to improve product longevity on the skin's surface and optimize tactile feel.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This copolymer is expected to maintain stability across a broad pH range of 4 to 9. Related polyurethane copolymers, such as Polyurethane-14, exhibit general stability under typical environmental conditions and are not anticipated to undergo significant hydrolysis or degradation within standard cosmetic formulations.
Safety
Safety Profile
Specific safety assessments for POLY(1,4-BUTANEDIOL)-27/BUTYLENE GLYCOL/IPDI COPOLYMER by major regulatory bodies (CIR, SCCS, FDA) are currently unavailable. However, other ingredients within the polyurethane family, such as BIS-HEA POLY(1,4-BUTANEDIOL)-9/IPDI COPOLYMER, have demonstrated low concerns regarding cancer, allergies, immunotoxicity, and developmental/reproductive toxicity according to EWG Skin Deep. The monomer 1,4-Butanediol, a component of this copolymer, has been noted as nonmutagenic, nonsensitizing, and a slight irritant in its unpolymerized form, with CIR identifying insufficient data for its safety as a standalone cosmetic ingredient. FDA warnings concerning 1,4-Butanediol are specifically related to human ingestion and do not apply to its topical cosmetic use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting a clear functional role as a binding and film-forming agent in cosmetic formulations, the absence of specific safety assessments and direct clinical efficacy data for this exact copolymer results in an 'insufficient-data' rating for its overall profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources